Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

20121,704 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 379, Issue 9813, pp. 315-321

Field-Weighted Citation Impact: 97.66